Rupert Baines appointed Chair of Cambridge Tech Week 2025: A vision for global impact
Cambridge Tech Week has always been a showcase for innovation, but in 2025, it’s set to shine even brighter under the leadership of Rupert Baines, the newly appointed Chair.
A new approach to tackle children's mental health
How long should a child have to wait for mental health support? Acteon, Cambridge BPI and the University of Cambridge to provide 11-18 year olds with supportive, scientifically backed resources while they wait.
Cambridge opens its doors: A week of innovation at the home of UK life sciences
The buzzing Cambridge Wide Open annual event returns in June, this time as a week-long interactive festival showcasing Cambridge’s pioneers, the companies of the future, and opening the offices and workspaces that make up one of the world’s most vibrant ecosystems.
Trust consultant honoured with Arnold Adolf Berthold award
An Addenbrooke’s honorary consultant who has won top accolades for his cutting-edge work has just been presented with another.
Arecor enters collaboration with major global pharmaceutical partner
Cambridge: Arecor Therapeutics plc, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that it has signed a formulation study agreement with a major global pharmaceutical partner.
Expert view: Unlocking marketing success with generative AI: A blueprint for SMEs
In the fast-paced world of marketing, staying ahead of the curve is not just a strategy; it's a necessity. Enter Generative AI, a powerful tool that can transform your marketing, even if you're not a tech wizard. Today, I'm here to demystify Generative AI, share success stories, and provide actionable tips for SMEs looking to harness its potential.
ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025
Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from 14–15 May
Global pharma R&D returns rise as GLP-1 drugs help drive forecast growth
The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs helping to boost growth, according to analysis by Deloitte.
FairJourney Biologics establishes Supervisory Board
Werner Lanthaler appointed as Chair and joined by global industry leadersThe Supervisory Board will define key avenues for growth, accelerate innovation, and optimize scientific strategies to maintain leadership in antibody discovery and development
WaveFX reach finals of SME National Business Awards for Best Enterprising Business
WaveFX, a leading event filming and webcasting company, is thrilled to announce that it has been named a finalist in the prestigious SME National Business Awards. The company is competing in the highly sought-after Best Enterprising Business category, recognizing its innovation, resilience, and outstanding contributions to the industry.
Lord Patrick Vallance, Science Minister and Oxford-Cambridge Innovation Champion, visits Cambridge
Science Minister and Oxford-Cambridge Innovation Champion, Lord Patrick Vallance, visited Cambridge to see how the world’s most intensive science and technology cluster can drive economic growth.
Gold-standard research: Cambridge growing faster than UK economy
Cambridge growing faster than national economy, but UK growth contribution at risk due to a start-up slow-down, according to new gold-standard research.
AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing
AstraZeneca announces an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance life sciences in China.
US Patent Office grants Closed Loop Medicine key patents for cardiometabolic capabilities in GLP-1 and Direct Oral Anti-Coagulants (DOAC) therapies
London, UK, 24 March 2025: Closed Loop Medicine Ltd., a leader in AI-enabled precision medicines, announces the expansion of its US patent portfolio.
Unlocking seamless connectivity: In-building wireless solutions are the future
In today’s fast-paced digital world, connectivity is no longer a luxury - it’s a necessity. From corporate offices to hospitals, sprawling warehouses and everything in between, the demand for reliable, high-performance wireless coverage has never been greater.
Innovations in healthcare delivery: Insights from China's Guanggu Model and beyond
In recent years, healthcare systems worldwide have faced significant challenges, including overcrowded hospitals, lengthy waiting times for specialist appointments, and inefficient resource allocation.
Doctor who shapes worldwide trauma care wins lifetime award
An Addenbrooke’s doctor who has worked on the frontline of emergency care for more than three decades – and is described as the architect of the East of England trauma network - has won a prestigious lifetime achievement award for his work.
More on private 5G
Bruce Lancaster, CEO, Wilson Connectivity, on the positioning of private 5G as a reliable option for secure, high-capacity and low-latency communication needs.
Cambridge assembles world-class tech and science leaders to steer innovation and growth blueprint
Cambridge: Innovate Cambridge is today unveiling its Advisory Council featuring global tech and science pioneers such as Professor Dame Ottoline Leyser (UKRI), Hermann Hauser (Arm, Amadeus Capital) and Stan Boland (FiveAI, Icera).
Official launch of this year's exciting 2025 Cambridge Dragon Boat Festival
Every year, Fen Ditton plays host to one of the most fun-filled, family-friendly events in the Cambridge calendar - the Cambridge Dragon Boat Festival. This year's event celebrates its 19th year - and marks the 30th birthday year of its host, Addenbrooke's Charitable Trust. With a bigger fundraising target than ever before - with all proceeds going towards the build of the Cambridge Cancer…
New AI tool visualises a cell’s ‘social network’ to help treat cancer
A first-of-its-kind artificial intelligence (AI)-based neural network can rapidly analyse and interpret millions of cells from a patient sample, predicting molecular changes in the tissue. It can potentially pinpoint where personalised treatments could be most effective for conditions such as cancer.
Acne vulgaris vaccines: time for something new
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis, publishes a brand-new global analysis focused on the potential for acne vulgaris vaccines.
Finding Clarity, Support and Momentum as an Innovation Entrepreneur
By Garry Jennings, Innovation Director, The EpiCentre
Sapio Sciences makes AI-native drug discovery seamless with NVIDIA BioNeMo
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle
